Roche’s Antibody Against Alzheimer’s Looks the Best Yet
Roche Holding has one of the most promising treatments for Alzheimer’s in clinical trials. The drug is several years away ...
STAT6d
Early data from Roche’s Alzheimer’s therapy show it’s hitting targets
An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug ...
AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday
The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier-bridging ...
BioSpace1d
7 Alzheimer’s and Parkinson’s Programs Discarded in 2024
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...
STAT5d
Pharmalittle: We’re reading about disappointing Lilly sales, a Roche Alzheimer’s therapy, and more
An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...
FierceBiotech13d
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...
FierceBiotech4d
Roche collects more data to support blood tests for diagnosing Alzheimer’s disease
Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...
Roche weighs whether speedy approval path is open for latest Alzheimer’s drug
In an investor presentation, executives hinted at the possibility of seeking an accelerated approval of trontinemab if it can ...
BioSpace13d
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease
New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s ...
The Boston Globe5d
Roche discloses patient death in Alzheimer’s trial
An elderly patient died in a clinical study of Roche’s experimental treatment for Alzheimer’s disease, prompting changes to the trial design, although the company said overall results support ...